Medifast [MED] vs Yy Group Holding [YYGH] Detailed Stock Comparison
Medifast
NYSE
Loading...
Yy Group Holding
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Medifast wins in 11 metrics, Yy Group Holding wins in 4 metrics, with 0 ties. Medifast appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Medifast | Yy Group Holding | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 42.88 | 20.23 | Yy Group Holding |
| Price-to-Book Ratio | 0.67 | 11.12 | Medifast |
| Debt-to-Equity Ratio | 6.05 | 81.32 | Medifast |
| PEG Ratio | -0.33 | N/A | N/A |
| EV/EBITDA | -0.16 | -15.19 | Yy Group Holding |
| Profit Margin (TTM) | 0.76% | -11.77% | Medifast |
| Operating Margin (TTM) | -1.01% | -26.81% | Medifast |
| Return on Equity | 1.73% | -93.74% | Medifast |
| Return on Assets (TTM) | 2.88% | -24.14% | Medifast |
| Free Cash Flow (TTM) | $17.02M | $-1.60M | Medifast |
| 1-Year Return | -29.18% | 155.41% | Yy Group Holding |
| Price-to-Sales Ratio (TTM) | 0.32 | 1.85 | Medifast |
| Enterprise Value | $-4.30M | $74.33M | Yy Group Holding |
| EV/Revenue Ratio | -0.01 | 1.81 | Medifast |
| Gross Profit Margin (TTM) | 72.61% | N/A | N/A |
| Revenue per Share (TTM) | $44 | $1 | Medifast |
| Earnings per Share (Diluted) | $0.33 | $-0.14 | Medifast |
| Beta (Stock Volatility) | 0.82 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Medifast vs Yy Group Holding Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Medifast | -3.43% | 7.28% | 2.61% | 1.00% | -0.98% | -18.16% |
| Yy Group Holding | -0.79% | -10.00% | -31.52% | 18.13% | 6.18% | 8.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Medifast | -29.18% | -89.47% | -91.51% | -49.46% | -49.59% | 243.45% |
| Yy Group Holding | 155.41% | -35.71% | -35.71% | -35.71% | -35.71% | -35.71% |
Performance & Financial Health Analysis: Medifast vs Yy Group Holding
| Metric | MED | YYGH |
|---|---|---|
| Market Information | ||
| Market Cap | $155.52M | $75.88M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 198,340 | 466,130 |
| 90 Day Avg. Volume | 211,303 | 365,830 |
| Last Close | $13.66 | $1.88 |
| 52 Week Range | $11.57 - $21.98 | $0.72 - $3.45 |
| % from 52W High | -37.83% | -45.65% |
| All-Time High | $336.99 (May 24, 2021) | $4.70 (Apr 22, 2024) |
| % from All-Time High | -95.95% | -60.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.37% | 0.21% |
| Quarterly Earnings Growth | -0.37% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | -0.12% |
| Operating Margin (TTM) | -0.01% | -0.27% |
| Return on Equity (TTM) | 0.02% | -0.94% |
| Debt to Equity (MRQ) | 6.05 | 81.32 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $21.04 | $0.17 |
| Cash per Share (MRQ) | $15.84 | $0.08 |
| Operating Cash Flow (TTM) | $4.15M | $-1,501,880 |
| Levered Free Cash Flow (TTM) | $10.69M | $-2,963,123 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Medifast vs Yy Group Holding
| Metric | MED | YYGH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 42.88 | 20.23 |
| Forward P/E | 47.17 | N/A |
| PEG Ratio | -0.33 | N/A |
| Price to Sales (TTM) | 0.32 | 1.85 |
| Price to Book (MRQ) | 0.67 | 11.12 |
| Market Capitalization | ||
| Market Capitalization | $155.52M | $75.88M |
| Enterprise Value | $-4,297,744 | $74.33M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.01 | 1.81 |
| Enterprise to EBITDA | -0.16 | -15.19 |
| Risk & Other Metrics | ||
| Beta | 0.82 | N/A |
| Book Value per Share (MRQ) | $21.04 | $0.17 |
Financial Statements Comparison: Medifast vs Yy Group Holding
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MED | YYGH |
|---|---|---|
| Revenue/Sales | $115.73M | N/A |
| Cost of Goods Sold | $31.48M | N/A |
| Gross Profit | $84.25M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-1.26M | N/A |
| EBITDA | $2.02M | N/A |
| Pre-Tax Income | $526,000 | N/A |
| Income Tax | $1.30M | N/A |
| Net Income (Profit) | $-772,000 | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MED | YYGH |
|---|---|---|
| Cash & Equivalents | $91.72M | $836,907 |
| Total Current Assets | $213.52M | $13.41M |
| Total Current Liabilities | $60.60M | $7.96M |
| Long-Term Debt | $8.45M | $1.13M |
| Total Shareholders Equity | $210.96M | $6.19M |
| Retained Earnings | $176.01M | $-4.29M |
| Property, Plant & Equipment | $46.32M | $129,687 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MED | YYGH |
|---|---|---|
| Operating Cash Flow | $2.62M | N/A |
| Capital Expenditures | $-1.52M | N/A |
| Free Cash Flow | $1.88M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-369,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MED | YYGH |
|---|---|---|
| Shares Short | 2.29M | 2,148 |
| Short Ratio | 11.35 | 0.01 |
| Short % of Float | 0.21% | 0.00% |
| Average Daily Volume (10 Day) | 198,340 | 466,130 |
| Average Daily Volume (90 Day) | 211,303 | 365,830 |
| Shares Outstanding | 10.94M | 36.10M |
| Float Shares | 9.15M | 10.89M |
| % Held by Insiders | 0.03% | 0.74% |
| % Held by Institutions | 0.80% | 0.00% |
Dividend Analysis & Yield Comparison: Medifast vs Yy Group Holding
| Metric | MED | YYGH |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $2.74 | N/A |
| 3-Year Avg Dividend Yield | 1.43% | N/A |
| 3-Year Total Dividends | $8.22 | N/A |
| Ex-Dividend Date | Jun 26, 2023 | N/A |